Inorganic phosphate removal during different dialytic procedures
- PMID: 3610368
Inorganic phosphate removal during different dialytic procedures
Abstract
In order to clarify the influence of membrane surface, membrane composition, dialysate buffer and convective transfer on the dialytic removal of inorganic phosphate (Pi), 11 uremic patients were studied. Each patient underwent 7 different dialysis techniques: conventional hemodialysis with acetate buffer and different surface or composition of the membrane, bicarbonate dialysis and a "soft" hemodiafiltration, also termed biofiltration, with post-dilution infusion of 4 liters. The treatment time was fixed at 4 hours. Our study showed that the dialyzer surface area and the ultrafiltration rate were the major factors in dialytic inorganic phosphorus (Pi) removal. The dialysate buffer does not modify dialytic Pi removal but may influence the rebound phenomenon.
Similar articles
-
Phosphate dialytic removal: enhancement of phosphate cellular clearance by biofiltration (with acetate-free buffer dialysate).Nephron. 1992;62(2):155-60. doi: 10.1159/000187025. Nephron. 1992. PMID: 1436307
-
[Factors which influence phosphorus removal in hemodialysis].Nefrologia. 2007;27(1):46-52. Nefrologia. 2007. PMID: 17402879 Spanish.
-
Removal of phosphate (Pi) by either bicarbonate dialysis or biofiltration in uremics.Int J Artif Organs. 1986 Dec;9 Suppl 3:35-8. Int J Artif Organs. 1986. PMID: 3557670
-
Acetate free biofiltration (AFB): from theory to clinical results.Clin Nephrol. 1998 Jul;50(1):28-37. Clin Nephrol. 1998. PMID: 9710344 Review.
-
Phosphate removal and hemodialysis conditions.Kidney Int Suppl. 2001 Feb;78:S190-4. doi: 10.1046/j.1523-1755.2001.59780190.x. Kidney Int Suppl. 2001. PMID: 11169009 Review.
Cited by
-
Safety of new phosphate binders for chronic renal failure.Drug Saf. 2003;26(15):1093-115. doi: 10.2165/00002018-200326150-00003. Drug Saf. 2003. PMID: 14640773 Review.
-
Hyperphosphatemia in Kidney Failure: Pathophysiology, Challenges, and Critical Role of Phosphorus Management.Nutrients. 2025 May 5;17(9):1587. doi: 10.3390/nu17091587. Nutrients. 2025. PMID: 40362897 Free PMC article. Review.
-
Hyperphosphataemia in renal failure: causes, consequences and current management.Drugs. 2003;63(6):577-96. doi: 10.2165/00003495-200363060-00005. Drugs. 2003. PMID: 12656655 Review.
-
Postdialysis serum phosphate equilibrium in hemodialysis patients on a controlled diet and no binders.Hemodial Int. 2022 Apr;26(2):255-263. doi: 10.1111/hdi.12999. Epub 2021 Dec 28. Hemodial Int. 2022. PMID: 34964250 Free PMC article.
-
Control of hyperphosphatemia and maintenance of calcemia in CKD.J Bras Nefrol. 2021 Dec 3;43(4 Suppl 1):632-638. doi: 10.1590/2175-8239-JBN-2021-S105. eCollection 2021. J Bras Nefrol. 2021. PMID: 34910797 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous